spacer
CDC Home > HIV/AIDSTopics > Statistics and Surveillance > Reports > Cases of HIV Infection and AIDS in the United States, 2003
Cases of HIV Infection and AIDS in the United States, 2003
space
arrow Cover
space
arrow Commentary
space
arrow Technical Notes
space
arrow Web Addresses for State HIV Infection and AIDS Surveillance Reports
space
 
LEGEND:
PDF Icon   Link to a PDF document
Non-CDC Web Link   Link to non-governmental site and does not necessarily represent the views of the CDC
Adobe Acrobat (TM) Reader needs to be installed on your computer in order to read documents in PDF format. Download the Reader.
spacer spacer
spacer
 
Skip Nav spacer
Technical Notes
spacer
spacer

Surveillance of HIV Infection (not AIDS)

This report includes data from case reports from 41 areas that had laws or regulations requiring confidential reporting by name for adults and adolescents and/or children with confirmed HIV infection (not AIDS), in addition to the reporting of persons with AIDS. Connecticut required reporting by name for children 13 years of age and younger. After the removal of personal identifying information, data from these reports were submitted to CDC (see Table 16 for list of areas). The implementation of HIV reporting has differed from state to state. Before 1991, surveillance of HIV infection (not AIDS) was not standardized, and the reporting of HIV infections (not AIDS) was based primarily on passive surveillance. The information on many of the cases reported before 1991 is not complete. Since then, CDC has assisted states in conducting active surveillance of HIV infections (not AIDS) by the use of standardized report forms and software.

Data on HIV infection (not AIDS) should be interpreted with caution. HIV surveillance reports may not be representative of all persons infected with HIV because not all infected persons have been tested. Many HIV-reporting states offer anonymous HIV testing, and home-collection HIV test kits are widely available in the United States. The results of anonymous tests are not reported to the confidential name-based HIV registries of state and local health departments. Therefore, reports of confidential test results may not represent all persons who tested positive for HIV infection. Furthermore, many factors, including the extent to which testing is routinely offered to specific groups, may influence testing patterns and the availability of, and access to, medical care and testing services. These data provide a minimum estimate of the number of persons known to be HIV infected in states with confidential HIV reporting.

As of December 31, 2003, 9 areas (California, Hawaii, Illinois, Kentucky, Maryland, Massachusetts, Rhode Island, Vermont, and the District of Columbia) had implemented a code-based system to conduct case surveillance for HIV infection (not AIDS). Other areas (Delaware, Maine, Montana, Oregon, and Washington) had implemented a name-to-code system for conducting HIV infection surveillance: initially, names are collected, and, after any necessary public health follow-up, names are converted to codes. Connecticut allows cases of HIV infection (not AIDS) in adults and adolescents to be reported by name or code; New Hampshire allows HIV cases to be reported with or without a name. Data on cases of HIV infection (not AIDS) from these areas are not included in the HIV data tables pending evaluations demonstrating acceptable performance according to CDC guidelines and pending the development of methods for reporting such data to CDC.

For this report, we classified cases in adults, adolescents, and children 18 months of age and older by using the 2000 revised HIV surveillance case definition, which incorporates positive test results or reports of a detectable quantity of HIV nucleic acid or plasma HIV RNA [1]. For children less than 18 months of age, the pediatric HIV reporting criteria reflect diagnostic advances that permit the diagnosis of HIV infection during the first months of life. By the use of HIV nucleic acid detection tests, HIV infection can be detected in nearly all infants aged 1 month and older. The timing of the HIV serologic and HIV nucleic acid detection tests specified in the definitive and presumptive criteria for HIV infection is based on the recommended practices for diagnosing infection in children aged less than 18 months and on evaluations of the performance of these tests for children in this age group. Children aged less than 18 months born to an HIV-infected mother are categorized as having been exposed perinatally to HIV infection if the child does not meet the criteria for HIV infection or the criteria for “not infected with HIV” [1, 2]. Children born before 1994 were considered HIV infected if they met the HIV case definition in the 1987 pediatric classification system for HIV infection [3].

Because states initiated reporting on different dates, the length of time reporting has been in place influences the number of HIV infection cases reported. For example, data presented for a given year may include cases reported during only a part of the year. Before statewide HIV reporting, some states collected reports of HIV infection (not AIDS) in selected populations. Therefore, these states have reports that precede the initiation of statewide confidential reporting. A state with confidential HIV infection reporting also may report persons who tested positive in that state but who were residents of other states. Therefore, when HIV data are presented by state of residence, cases reported before a state initiated reporting may have been reported from other states that did have confidential HIV infection reporting.

Over time, HIV infection may progress to AIDS and be reported to surveillance. Persons with HIV infection (not AIDS) who are later reported as having AIDS are deleted from the HIV infection (not AIDS) tables and added to the AIDS tables. Persons with HIV infection may be tested at any point on the clinical spectrum of disease; therefore, the time between diagnosis of HIV infection and diagnosis of AIDS differs. In addition, because surveillance practices differ, the reporting and updating of persons’ clinical and vital status differ among states. Completeness of reporting for HIV infection (not AIDS) is estimated at more than 85% [4].

Surveillance of AIDS
All 50 states, the District of Columbia, and U.S. dependencies, possessions, and associated nations report AIDS cases to CDC by using a uniform surveillance case definition and case report form. The original definition was modified in 1985 and 1987 [5, 6]. The case definition for adults and adolescents was modified again in 1993 [7; see also 8]. The revisions incorporated a broader range of AIDS-indicator diseases and conditions and used HIV diagnostic tests to improve the sensitivity and specificity of the definition. The laboratory and diagnostic criteria for the 1987 pediatric case definition [3] were updated in 1994 [9]. Effective January 1, 2000, the surveillance case definition for HIV infection was revised to reflect advances in laboratory HIV virologic tests. The definition incorporates the reporting criteria for HIV infection and AIDS into a single case definition for adults and children [1].

For persons with laboratory-confirmed HIV infection, the 1987 revision incorporated encephalopathy, wasting syndrome, and other indicator diseases that are diagnosed presumptively (i.e., without confirmatory laboratory evidence of opportunistic infection). In addition to the 23 clinical conditions in the 1987 definition, the 1993 case definition for adults and adolescents includes HIV infection among persons with CD4+ T-lymphocyte counts of less than 200 cells/µL or a CD4+ percentage of less than 14 and a diagnosis of pulmonary tuberculosis, recurrent pneumonia, or invasive cervical cancer. For adults, adolescents, and children 18 months of age and older, the 2000 revised HIV surveillance case definition incorporates positive test results or reports of a detectable quantity of HIV nucleic acid or plasma HIV RNA.

The pediatric case definition incorporates the revised 1994 pediatric classification system for evidence of HIV infection. Cases among children with their first positive results by Western blot or HIV detection tests before October 1994 were categorized according to the 1987 classification system. For children of any age with an AIDS-defining condition that requires evidence of HIV infection, a single positive HIV virologic test result (i.e., HIV nucleic acid [DNA or RNA], HIV viral culture, HIV p24 antigen) is sufficient for a reportable AIDS diagnosis if the diagnosis is documented by a physician.

Although completeness of reporting of AIDS cases to state and local health departments differs by geographic region and patient population, studies conducted by state and local health departments indicate that the reporting of AIDS cases in most areas of the United States is more than 85% complete [10, 11, 12, 13]. In addition, multiple routes of exposure, opportunistic infections diagnosed after the initial AIDS case report was submitted to CDC, and vital status may not be determined or reported for all cases. However, for persons reported as having AIDS, the reporting of deaths is estimated to be more than 90% complete [14]. CDC estimates that less than 5% of HIV and AIDS cases in the national surveillance database are duplicates.

Since January 1, 1994, CDC has not accepted AIDS case reports that meet only the laboratory-based immunologic criteria of the 1993 expanded surveillance case definition [7] if information on sex or race/ethnicity was missing. A small number of cases previously reported to CDC without those variables have been returned to the health departments for follow-up and have been deleted from the totals.

Tabulation and Presentation of Data
Data in this report are provisional. This report includes information received by CDC through June 30, 2005. For analyses of cases of HIV infection, we used data from 35 areas (i.e., 33 states, Guam and the U.S. Virgin Islands) that have had HIV infection reporting for a sufficient time (i.e., at least since 2000) to allow for stabilization of data collection and for adjustment of the data in order to monitor trends.

This report is organized in 5 sections. In Sections 1–3 (i.e., Tables 1–12, Figure 1, and Maps 1 and 2), data have been statistically adjusted to correct for delays in the reporting of cases and deaths; unreported risk factors have been statistically redistributed to better present the trends in the epidemic and the distribution of risk characteristics among affected populations. To assess trends in cases, deaths, or prevalence, it is preferable to use adjusted data, presented by year of diagnosis instead of year of report. Section 4, which presents survival data, is discussed later in the Technical Notes. In Section 5 (Tables 14–23), HIV and AIDS data are tabulated by date of report to CDC. Data for the U.S. dependencies, possessions, and associated nations are included in the table totals unless their exclusion is specified in a footnote. The U.S. dependencies, possessions, and associated nations comprise Puerto Rico, the U.S. Virgin Islands, Guam, American Samoa, and the Commonwealth of the Northern Mariana Islands. The last 2 areas constitute the category of Pacific Islands, U.S., as listed in this report.

Selection of areas with mature HIV reporting systems for analysis of cases of HIV/AIDS and HIV infection (not AIDS)
The inclusion of areas with mature (i.e. since at least 2000) confidential name-based HIV reporting for tabulation and presentation of HIV/AIDS and HIV infection (not AIDS) data was based on the date of the implementation of HIV reporting in the area and the ability to calculate 4 years of reporting delays in order to display trends reliably. For this report, 35 areas with laws or regulations requiring confidential name-based HIV infection reporting since 2000 were eligible for inclusion. The 35 areas are Alabama, Alaska, Arizona, Arkansas, Colorado, Florida, Idaho, Indiana, Iowa, Kansas, Louisiana, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New Jersey, New Mexico, New York, Nevada, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, West Virginia, Wisconsin, Wyoming, Guam, and the U.S. Virgin Islands.

Selection of areas for analyses of reports of HIV infection (not AIDS)
Areas included in tabulations for reports of HIV infection (not AIDS) are based on the date of implementation of name-based HIV infection reporting before the end of 2004. For Tables 16, 18, 20, and 22, we used data from 42 areas to describe reports of cases of HIV infection (not AIDS).

Age groups
For Tables 8-12 and Maps 1 and 2, age groups of persons living with HIV/AIDS, HIV infection (not AIDS), or AIDS are based on the person’s age as of December 31, 2004. For Table 7, age groups of persons who died with AIDS are based on the person’s age at the time of death. For all other tables, age groups are based on the person’s age at the first documented positive HIV-antibody test result for persons with a diagnosis of HIV infection (not AIDS), and age at diagnosis of AIDS for persons with a diagnosis of AIDS. The age category for adults and adolescents comprises persons age 13 years and older; the age category for children comprises children younger than 13 years of age.

Race and ethnicity
In the Federal Register for October 30, 1997 [15], the Office of Management and Budget announced the Standards for Maintaining, Collecting, and Presenting Federal Data on Race and Ethnicity, also known as Statistical Policy Directive 15. These standards, which superseded the 1977 standards, reflected a change in federal policy regarding the collection of race and ethnicity data; implementation by January 1, 2003 was mandated. At a minimum, data on the following race categories should be collected:

  • American Indian or Alaska Native
  • Asian
  • black or African American
  • Native Hawaiian or Other Pacific Islander
  • white

Additionally, systems must be able to retain information when multiple racial categories are reported. Two ethnicity categories should be collected regardless of race:

  • Hispanic
  • not Hispanic.

Because data for this document were compiled from reports to CDC through June 2005, race and ethnicity information were collected under 2 systems. The race and ethnicity categories in the system used through December 2002 are maintained in this document because most case reports were submitted under that system. Persons who reported multiple racial categories or whose race was unknown are included in the total numbers in Tables 1–5, 7–11, 13, and 19–23. Also, persons reported as non-Hispanic may include persons whose ethnicity was not reported.

Tabulation of cases of HIV/AIDS and AIDS
In this report, the term HIV/AIDS is used to refer to 3 categories of cases: (1) new diagnoses of HIV infection (not AIDS), (2) new diagnoses of HIV infection with later diagnoses of AIDS, and (3) concurrent diagnoses of HIV infection and AIDS. For analyses of HIV/AIDS data, we used data from 33 areas (i.e., 32 states and the U.S. Virgin Islands) that have had HIV infection reporting for a sufficient length of time (i.e., at least since 1999) to allow for stabilization of data collection and for adjustment of the data in order to monitor trends. Tables 1, 2, 8, and 9 summarize cases and prevalence of HIV/AIDS. For analysis of AIDS cases, we used data from the 50 states, the District of Columbia, U.S. territories and other associated nations.

Tabulation of persons living with HIV/AIDS, AIDS, and HIV infection (not AIDS)
Tabulation of persons living with HIV/AIDS, HIV infection (not AIDS), or with AIDS (Tables 8, 9, 10, 11, and 12 and Maps 1 and 2) include persons whose vital status was reported as “alive” as of the last update of the data; persons whose vital status is missing or unknown are not included. Tabulations of deaths of persons with AIDS (Table 7) include persons whose vital status was reported as “dead” as of the last update; persons whose vital status is missing or unknown are not included. Caution should be used in interpreting these data because states differ in how often they review the vital status of persons reported with HIV/AIDS, HIV infection (not AIDS), or with AIDS. In addition, some cases may be lost to follow-up.

Geographic designations
Regions of residence included in the report are defined as follows.

  • Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont
  • Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin
  • South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia
  • West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming
  • U.S. dependencies, possessions, and associated nations: Guam, Puerto Rico, the U.S. Pacific Islands, and the U.S. Virgin Islands.

Survival analyses
For the survival analyses presented in Section 4, Table 13 and Figures 2–4, we used time analysis methods for calculating survival versus death for AIDS case data reported through June 30, 2003. Table 13 was limited to AIDS cases diagnosed in 1999, and Figures 2–4 were limited to cases diagnosed during 19956–2002. Table 13 and the figures were limited to deaths through December 2003; this was done to allow at least 6 months for a death to be reported by June 30, 2004, and to allow at least 1 month after AIDS diagnosis.

Transmission Categories
Transmission category is the term for the classification of cases that summarizes a person’s possible HIV transmission risk factors; the summary classification results from selecting, from the presumed hierarchical order of probability, the 1 risk factor most likely to have been responsible for transmission. For surveillance purposes, cases of HIV/AIDS, HIV infection (not AIDS), and AIDS are counted only once in the hierarchy of transmission categories. Persons with more than one reported risk factor for HIV are classified in the transmission category listed first in the hierarchy. The exception is men who report sexual contact with other men and injection drug use; this group makes up a separate transmission category.

Persons whose transmission category is classified as male-to-male sexual contact include men who report sexual contact with other men (i.e., homosexual contact) and men who report sexual contact with both men and women (i.e., bisexual contact). Persons whose transmission category is classified as heterosexual contact are persons who report specific heterosexual contact with a person with, or at increased risk for, HIV infection (e.g., an injection drug user).

Adults and adolescents born in, or who had sex with someone born in, a country where heterosexual transmission was believed to be the predominant mode of HIV transmission (formerly classified as Pattern II countries by the World Health Organization) are no longer classified as having heterosexually acquired HIV infection unless they meet the criteria stated in the preceding paragraph. Similar to other cases in persons who were reported without information about a behavioral or a transfusion risk factor for HIV infection, these cases are classified (in the absence of other risk factor information that would classify them in another transmission category) as “no risk factor reported or identified” [16]. Cases in children whose mother was born in, or whose mother had sex with someone born in, Pattern II countries are now classified (in the absence of other risk factor information that would classify them in another transmission category) as “Mother with documented HIV infection, a risk factor for HIV infection, or HIV infection without a specified risk factor.”

Cases in persons with no reported risk factor for HIV through any of the routes listed in the hierarchy of transmission categories are classified as “no risk factor reported or identified.” These cases include persons that are being followed up by local health department officials; cases in persons whose risk factor history is incomplete because they died, declined to be interviewed, or were lost to follow-up; and cases in persons who were interviewed or for whom other follow-up information was available and no mode of transmission was identified.

As of September 2000, the procedures for investigating cases reported without risk factor information changed from ascertaining a risk factor for all reported cases to estimating risk factor distributions from statistical models and population-based samples. States continue to investigate any report of an unusual exposure to HIV and report these cases to CDC. CDC will continue to tabulate the number of documented unusual exposures to HIV reported by the states.

Because recently reported cases of HIV infection or AIDS are more likely to be reported without sufficient risk factor information, recent AIDS incidence in some transmission categories will be underestimated unless an adjustment is made. For tables and figures showing the estimated cases of HIV infection (not AIDS) and AIDS, the adjustment of cases without risk factor information among adults and adolescents is based on the redistributions of transmission category, by specific sex, race, and region, of cases that were diagnosed during 1992–1999 and initially assigned to the “no identified risk factor” category but that were later reclassified. Similar adjustments of such cases among children are based on transmission-category redistribution of all cases diagnosed during that period and later reclassified [17, 18].

Reporting Delays
Reporting delays (time between diagnosis of HIV infection or AIDS and report to CDC) may differ among exposure, geographic, racial/ethnic, age, sex, and vital status categories; for some AIDS cases, delays have been as long as several years. Adjustments of the estimated data on HIV infection (not AIDS) and on AIDS to account for reporting delays are calculated by a maximum likelihood statistical procedure. This procedure not only takes into account the differences in reporting delays among exposure, geographic, racial/ethnic, age, sex, and vital status categories, it is based on the assumption that reporting delays in these categories have not changed over time [19, 20]

Rates
Rates per 100,000 population were calculated for the numbers of AIDS cases in 2003, as well as for persons living with HIV infection (not AIDS) at the end of 2003. Population denominators used to compute these rates for the 50 states and the District of Columbia were based on official postcensus estimates for 2003 from the U.S. Census Bureau [21] and bridged-race estimates for 2002 obtained from the National Center for Health Statistics [22]. The bridged estimates are based on the Census 2000 counts and produced under a collaborative agreement with the U.S. Census Bureau. These estimates result from bridging the 31 race categories used in Census 2000, as specified in the 1997 Office of Management and Budget standards [15] for the classification of data on race and ethnicity, to the 4 race categories specified in the 1977 standards. Population denominators for U.S. dependencies, possessions, and associated nations were based on official postcensus estimates and Census 2000 counts from the U.S. Census Bureau’s International Database. Each rate is calculated by dividing the number of cases reported during the 12 months in 2003 (or the number of persons living with HIV infection or with AIDS at the end of 2003) by the 2003 population, multiplied by 100,000. The denominators used for computing age-, sex-, and race-specific rates are computed by applying the age, sex, and race proportions from the bridged-race population estimates for 2000 to the 2003 postcensus estimates of the total population for each state. When bridged-race population denominators for the U.S. dependencies, possessions, and associated nations were not available, proportions from the U.S. Census Bureau’s International Database for 2000 were used to estimate the age-, and sex-specific subpopulations [23].

References

  • CDC. Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR 1999;48(No. RR-13):29-31.
  • CDC. Guidelines for the use of antiretroviral agents in pediatric HIV infection. MMWR 1998;47(No. RR-4):1-43.
  • CDC. Current trends: classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR 1987; 36:225-230, 235.
  • CDC. Diagnosis and reporting of HIV and AIDS in states with integrated HIV and AIDS surveillance—United States, January 1994–June 1997. MMWR 1998; 47:309-314.
  • CDC. Current trends: revision of the case definition of acquired immunodeficiency syndrome for national reporting―United States. MMWR 1985; 34:373-375.
  • CDC. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987;36(No. SS-1):1S-15S.
  • CDC. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41(No. RR-17):1-19.
  • CDC. Current trends update: acquired immunodeficiency syndrome―United States, 1994. MMWR 1995; 44:64-67.
  • CDC. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age; official authorized addenda: human immunodeficiency virus infection codes and official guidelines for coding and reporting ICD-9-CM. MMWR 1994;43(No. RR-12):1-19.
  • Buehler JW, Berkelman RL, Stehr-Green JK. The completeness of AIDS surveillance. J Acquire Immune Defic Syndr 1992;5:257-264.
  • Rosenblum L, Buehler JW, Morgan MW, et al. The completeness of AIDS case reporting, 1988: a multisite collaborative surveillance project. Am J Public Health 1992;82:1495-1499.
  • Schwarcz SK, Hsu LC, Parisi MK, Katz MH. The impact of the 1993 AIDS case definition on the completeness and timeliness of AIDS surveillance. AIDS 1999;13:1109-1114.
  • Klevens RM, Fleming PL, Li J. The completeness, validity, and timeliness of AIDS surveillance data. Ann Epidemiol 2001;11:443-449.
  • Karon JM, Rosenberg PS, McQuillan G, Khare M, Gwinn M, Petersen LR. Prevalence of HIV infection in the United States, 1984 to 1992. JAMA 1996;276:126-131.
  • National Archives and Records Administration. Revisions to the standards for the classification of federal data on race and ethnicity. Federal Register 1997;62:58781-58790. Available at: http://www.whitehouse.gov/omb/fedreg/ombdir15.html.
  • CDC. Current trends: heterosexually acquired AIDS—United States, 1993. MMWR 1994; 43:155-160.
  • Green TA, Karon JM, Nwanyanwu OC. Changes in AIDS incidence trends in the United States. J Acquir Immune Defic Syndr 1992;5:547-55.
  • Neal JJ, Fleming, PL, Green TA, Ward JW. Trends in heterosexually acquired AIDS in the United States, 1988 through 1995. J Acquire Immune Defic Syndr Hum Retrovirol 1997;14: 465-474.
  • Green TA. Using surveillance data to monitor trends in the AIDS epidemic. Stat Med 1998;17:143-54.
  • Karon JM, Devine OJ, Morgan WM. Predicting AIDS incidence by extrapolating from recent trends. In: Castillo-Chavez C, ed. Mathematical and Statistical Approaches to AIDS Epidemiology. Berlin: Springer-Verlag; 1989:83:58-88. Lecture Notes in Biomathematics.
  • U.S. Census Bureau. Population estimates: entire data set. Available at: http://www.census.gov/ popest/datasets.html. Accessed November 1, 2004.
  • National Center for Health Statistics. Datasets available at: ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/
    datasets/nvss/bridgepop/ pcen_v2003.txt
    . Accessed November 1, 2004.
  • U.S. Census Bureau. Census 2000: the island areas. Available at: http://www.census.gov/population/www/
    cen2000/islandareas.html
    . Accessed November 1, 2004.
spacer
Last Modified: March 21, 2006
Last Reviewed: March 21, 2006
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
spacer
spacer
spacer
Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
spacer
spacer
spacer Safer, Healthier People
spacer
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov
spacer USA.gov: The U.S. Government's Official Web PortalDHHS Department of Health
and Human Services